Saint Louis University - Center for Vaccine Development — St Louis, Missouri

Saint Louis University - Center for Vaccine Development is a clinical research site located in St Louis, Missouri, United States 63104-1015.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Saint Louis University - Center for Vaccine Development has participated in 32 clinical trials.

Therapeutic areas: COVID-19, Influenza, Avian Influenza.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Access to Advanced Health Institute (AAHI).

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Saint Louis University - Center for Vaccine Development?

Saint Louis University - Center for Vaccine Development has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Saint Louis University - Center for Vaccine Development conducted?

Saint Louis University - Center for Vaccine Development has 32 clinical trials on record. Their work covers COVID-19, Influenza, Avian Influenza.

Is Saint Louis University - Center for Vaccine Development accredited by Crixeo Health?

Yes — Saint Louis University - Center for Vaccine Development holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Saint Louis University - Center for Vaccine Development?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.